They expect initial phase 3 results first half of 2022. A bit early to be hiring sales reps. Remestemcel-L, however, could qualify for EUA in the near term.
They expect initial phase 3 results first half of 2022. A bit...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
-0.010(1.04%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 95.0¢ | $269.4K | 281.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 17460 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.5¢ | 26405 | 10 |
View Market Depth
| Last trade - 10.15am 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |